A Phase 2 Multi-Center, Randomized Conversion Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belatacept Administered to Pediatric Subjects With a Stable Renal Transplant
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2018
At a glance
- Drugs Belatacept (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 06 Jun 2018 Results presented at the 2018 American Transplant Congress
- 16 Feb 2017 Status changed from active, no longer recruiting to completed.
- 26 Jul 2016 Planned End Date changed from 1 Oct 2016 to 1 Dec 2016.